WILMINGTON, N.C., Nov. 3, 2011 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive Vice President and Chief Financial Officer, are scheduled to present at the Lazard Capital Markets 8th Annual Healthcare Conference in New York, NY, November 16, 2011 at 10:30 a.m. ET. They will discuss the Company and its progress toward gaining market share with its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region and will also conduct one-on-one meetings with institutional investors. Investors that wish to request a meeting with TranS1 should contact Lazard Capital Markets.
